Structural Heart Occlusion Devices Market - Global Forecast 2026-2032

The structural heart occlusion devices market is advancing as clinical standards, procurement priorities, and device technologies evolve, prompting senior leaders to re-examine strategies for product selection, commercialization, and operational adaptation.

Market Snapshot: Structural Heart Occlusion Devices Market

The global structural heart occlusion devices market expanded from USD 1.53 billion in 2025 to USD 1.65 billion in 2026, and is projected to maintain a 7.04% compound annual growth rate (CAGR), reaching USD 2.47 billion by 2032. This growth trajectory highlights intensified competition and ongoing transformation, as emerging technologies, material shifts, and new regulatory landscapes drive changes in clinical adoption and procurement patterns. The market’s momentum is fueled by improvements in device design, shifting clinical guidelines, and evolving reimbursement frameworks, directly impacting the pace and quality of adoption worldwide.

Scope & Segmentation: Core Areas and Market Structure

Therapy Segments: The market addresses atrial septal defect closure, patent foramen ovale interventions, and ventricular septal defect repairs, each imposing distinct product development and regulatory requirements on manufacturers.
Access Route Types: Devices are engineered for both surgical and transcatheter implantation, supporting femoral, transseptal, and open surgical approaches in cardiovascular interventions.
End-User Settings: Deployment environments include hospitals across teaching and non-teaching categories, as well as ambulatory surgical centers and specialized cardiac facilities, shaping procurement and usage dynamics.
Material Types: Nitinol and biomaterial alternatives drive differentiation through attributes like enhanced durability, sharper imaging compatibility, and varying clinical acceptance, directly influencing product selection.
Distribution Channels: Distribution encompasses direct sales, collaborations with independent distributors, and emerging digital procurement platforms, offering varied approaches to training, inventory, and local support needs.
Regional Markets: Geographic coverage includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting a diverse spectrum of regulatory conditions and commercialization strategies as adoption grows region by region.
Technology Advances: Recent innovation focuses on imaging precision, device miniaturization, and integrated navigation systems, collectively improving procedural outcomes and streamlining clinical workflows.

Key Takeaways for Decision-Makers

Device selection now requires careful alignment of clinical evidence with operational requirements, as material and design advances expand patient eligibility and reduce time-to-treatment across key segments.
Improvements in advanced imaging and evolving reimbursement models are prompting broader adoption within both specialist and non-specialist care environments, impacting procurement strategies and organizational care delivery models.
Market participants need clear segmentation strategies, recognizing differing requirements around device categories, access modalities, care settings, and regional practices.
Supply chain agility and local sourcing are increasingly relevant, with provider organizations expecting both transparency and adaptability from device manufacturers in response to global sourcing pressures.
Manufacturers who invest in robust clinical evidence generation and offer tailored clinician engagement, such as targeted training and procedural proctoring, can differentiate their market presence and accelerate adoption.
Integrated commercial and product strategies that consider total procedural cost, not just unit price, now provide competitive advantages in procurement negotiations.

Tariff Impact on Supply Chain and Commercial Strategy

Recent modifications in United States tariff policy have raised device manufacturers’ concerns around sourcing and supply chain resilience, particularly due to increased tariffs on imported precision alloys and specialty fabrics. These changes have triggered a re-evaluation of supply networks, encouraging a shift toward supplier diversification or local assembly. As a result, procurement teams are placing heightened emphasis on transparency and comprehensive value demonstration, with commercial discussions increasingly focused on total procedural expense rather than simple unit pricing metrics. This has required all market participants to enhance adaptability and clarity across the supply chain, underlining the importance of end-to-end cost management and information sharing for successful commercialization.

Structural Heart Occlusion Devices Market: Methodology & Data Sources

Market findings are based on primary interviews with clinical leaders, procurement specialists, and industry executives, supplemented by structured review of regulatory filings, official device documentation, and peer-reviewed academic literature. Comparative analysis of procedural and stakeholder insights reinforces the reliability and decision value of the assembled intelligence.

Why This Report Matters

Empowers healthcare leadership and suppliers with actionable intelligence for optimizing product portfolios, directing R&D investments, and designing market entry or access strategies in the structural heart occlusion devices segment.
Clarifies the operational impacts of regulatory alterations, evolving reimbursement models, and unique regional factors, enabling more precise decision-making throughout product lifecycles and during commercial negotiations.
Supports long-term market resilience and adoption through a strategic understanding of supply chain trends, clinician education requirements, and evolving procurement behaviors favoring value-centric solutions over unit cost alone.

Conclusion: Integrated Strategies for Durable Market Adoption

Long-term success in the structural heart occlusion devices market depends on aligning clinical, operational, and supply chain strategies through organizational collaboration. Meeting the needs of evolving regulatory and clinical environments, while staying focused on value, positions firms for sustainable and differentiated market presence.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Structural Heart Occlusion Devices Market, by Product Type

8.1. Atrial Septal Defect Devices
8.2. Patent Foramen Ovale Devices
8.3. Ventricular Septal Defect Devices

9. Structural Heart Occlusion Devices Market, by Access Method

9.1. Surgical
9.1.1. Minimally Invasive
9.1.2. Open Heart
9.2. Transcatheter
9.2.1. Femoral Approach
9.2.2. Transseptal Approach

10. Structural Heart Occlusion Devices Market, by Material Type

10.1. Biomaterial
10.2. Nitinol

11. Structural Heart Occlusion Devices Market, by Distribution Channel

11.1. Direct Sales
11.2. Distributors
11.3. Online

12. Structural Heart Occlusion Devices Market, by End User

12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.2.1. Non-Teaching
12.2.2. Teaching
12.3. Specialty Cardiac Centers

13. Structural Heart Occlusion Devices Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Structural Heart Occlusion Devices Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Structural Heart Occlusion Devices Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Structural Heart Occlusion Devices Market
17. China Structural Heart Occlusion Devices Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Artivion, Inc.
18.7. Boston Scientific Corporation
18.8. Braile Biomédica Indústria e Comércio de Aparelhos Cirúrgicos S.A.
18.9. Comed B.V.
18.10. Edwards Lifesciences Corporation
18.11. JenaValve Technology, Inc.
18.12. Lepu Medical Technology (Beijing) Co., Ltd.
18.13. LifeTech Scientific Corporation
18.14. LivaNova PLC
18.15. Medtronic plc
18.16. Meril Life Sciences Pvt. Ltd.
18.17. MicroPort Scientific Corporation
18.18. Occlutech International AB
18.19. Shanghai Shape Memory Alloy Co., Ltd.
18.20. Shenzhen Lifetech Scientific Co., Ltd.
18.21. Terumo Corporation
18.22. Venus Medtech (Hangzhou) Inc.
18.23. W. L. Gore & Associates, Inc.

List of Figures

FIGURE 1. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OPEN HEART, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OPEN HEART, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OPEN HEART, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY FEMORAL APPROACH, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY FEMORAL APPROACH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY FEMORAL APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSSEPTAL APPROACH, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSSEPTAL APPROACH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSSEPTAL APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY BIOMATERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY BIOMATERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY BIOMATERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NON-TEACHING, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NON-TEACHING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NON-TEACHING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TEACHING, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TEACHING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TEACHING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 104. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 107. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 108. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 109. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. EUROPE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 122. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 124. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 125. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 126. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 127. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 128. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 144. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 145. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 146. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 147. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. ASEAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 153. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 154. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 155. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 156. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. GCC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 168. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 171. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 172. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 173. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 174. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. BRICS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 177. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 180. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 181. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 182. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 183. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. G7 STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 186. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 189. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 190. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 191. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 192. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. NATO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 205. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ACCESS METHOD, 2018-2032 (USD MILLION)
TABLE 208. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 209. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TRANSCATHETER, 2018-2032 (USD MILLION)
TABLE 210. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 211. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

Abbott Laboratories
Artivion, Inc.
Boston Scientific Corporation
Braile Biomédica Indústria e Comércio de Aparelhos Cirúrgicos S.A.
Comed B.V.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
LifeTech Scientific Corporation
LivaNova PLC
Medtronic plc
Meril Life Sciences Pvt. Ltd.
MicroPort Scientific Corporation
Occlutech International AB
Shanghai Shape Memory Alloy Co., Ltd.
Shenzhen Lifetech Scientific Co., Ltd.
Terumo Corporation
Venus Medtech (Hangzhou) Inc.
W. L. Gore & Associates, Inc.

Table Information

Report Attribute	Details
No. of Pages	187
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.65 Billion
Forecasted Market Value ( USD ) by 2032	$ 2.47 Billion
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	19

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Structural Heart Occlusion Devices Market

Scope & Segmentation: Core Areas and Market Structure

Key Takeaways for Decision-Makers

Tariff Impact on Supply Chain and Commercial Strategy

Structural Heart Occlusion Devices Market: Methodology & Data Sources

Why This Report Matters

Conclusion: Integrated Strategies for Durable Market Adoption

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Structural Heart Occlusion Devices Market Size, Share & Trends Analysis Report by Type (Left Atrial Appendage (LAA) Occlusion Devices, Atrial Septal Defect (ASD) Occluders), End-use (Hospitals, Specialty Clinics), and Region with Growth Forecasts, 2025-2030

Structural Heart Occlusion Devices Market Outlook 2026-2034: Market Share, and Growth Analysis

Structural Heart Occlusion Device Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Structural Heart Occlusion Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

Transcatheter Embolization and Occlusion Devices - Global Strategic Business Report